Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial.

Autor: Werlenius K; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Kinhult S; Department of Oncology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden., Solheim TS; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Cancer Clinic, St Olavs Hospital, Trondheim, Norway., Magelssen H; Department of Oncology, Oslo University Hospital, Oslo, Norway., Löfgren D; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Mudaisi M; Department of Oncology, Linköping University Hospital, Linköping, Sweden.; The Finnmark Hospital, Hammerfest, Norway., Hylin S; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden., Bartek J Jr; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.; Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark., Strandéus M; Department of Oncology, County Hospital Ryhov, Jönköping, Sweden., Lindskog M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Pelvic Cancer, Section of Genitourinary Oncology, Karolinska University Hospital, Stockholm, Sweden., Rashid HB; Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Carstam L; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Gulati S; Department of Neurosurgery, St Olavs Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway., Solheim O; Department of Neurosurgery, St Olavs Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway., Bartek J; Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden.; Danish Cancer Society Research Center, Copenhagen, Denmark., Salvesen Ø; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway., Jakola AS; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Neurosurgery, St Olavs Hospital, Trondheim, Norway.

Publikováno v: JAMA network open [JAMA Netw Open] 2023 Mar 01; Vol. 6 (3), pp. e234149. Date of Electronic Publication: 2023 Mar 01.

PO-111 Blood group B is a potent risk factor for venous thromboembolism in glioblastoma multiforme

Autor: Heenkenda, K.M., Malmström, A., Lysiak, M., Mudaisi, M., Bratthäll, C., Milos, P., Strandeus, M., Åkesson, L., Söderkvist, P., Uppugunduri, S., Osman, A.M.

Publikováno v: In Thrombosis Research April 2021 200 Supplement 1:S80-S80

CN57 - Does individual genetic background predict acute radiation skin reactions in women undergoing adjuvant breast cancer radiotherapy?

Autor: Oliva, D., Lewin, F., Lewin, N., Nilsson, M.P., Strandéus, M., Andersson, B.-Å, Sharp, L.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8

Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.

Autor: Jakola AS; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Neurosurgery, St. Olavs Hospital, Trondheim, Norway.; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Werlenius K; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Mudaisi M; Department of Oncology, Linköping University Hospital, Linköping, Sweden., Hylin S; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden., Kinhult S; Department of Oncology, Skåne University Hospital, Lund, Sweden., Bartek J Jr; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden., Salvesen Ø; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway., Carlsen SM; Department of Cancer Research and Molecular medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Endocrinology, St. Olavs Hospital, Trondheim, Norway., Strandéus M; Department of Oncology, County Hospital Ryhov, Jönköping, Sweden., Lindskog M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Section of Oncology, Akademiska University Hospital, Uppsala, Sweden., Löfgren D; Department of Oncology, Örebro University Hospital, Örebro, Sweden., Rydenhag B; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Carstam L; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Gulati S; Department of Neurosurgery, St. Olavs Hospital, Trondheim, Norway.; Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway., Solheim O; Department of Neurosurgery, St. Olavs Hospital, Trondheim, Norway.; Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway., Bartek J; Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Science for Life Laboratory,, Karolinska Institute, Stockholm, Sweden.; Research Center, Danish Cancer Society, Copenhagen, Denmark., Solheim T; European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Cancer Clinic, St. Olavs Hospital, Trondheim, Norway.

Publikováno v: F1000Research [F1000Res] 2018 Nov 15; Vol. 7, pp. 1797. Date of Electronic Publication: 2018 Nov 15 (Print Publication: 2018).